Industrial News-News Center-Jinan Liangfu Jinghe Pharmaceutical Technology Co., Ltd.

News Center

	Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China
	Tel: Sales: +86-531-88811783 Evaluation:+86-531-88806178 R&D: +86-531-88813691 Office: +86-531-88817621
	Fax: +86-531-88817925
	Zip Code: 250101
	Email: Trade Department: sales@trio-pharmatech.com G&D&E: register@trio-pharmatech.com yzxpj@trio-pharmatech.com R&D center:: newdrugs@trio-pharmatech.com

Industrial News

Now Position:Home > News Center > Industrial News

·	Japanese research a new anticancer drug	2014-10-25
·	New anticancer medicine can effectively inhibit 8 kinds of cancer	2014-10-18
·	In 2024 the global antibody drug conjugates market will reach 10 billion	2014-10-14
·	HHS:4 new kinds of carcinogen	2014-10-14
·	Shandong Province speeds up the drug registration to encourage drug innovation	2014-10-14
·	LYMPHOSEEK was approved to treat head and neck cancer by the FDA	2014-09-12
·	The Market Pattern of Statins in China	2014-09-12
·	N/A	2014-08-01
·	N/A	2014-08-01
·	Lo Sheyavastin for cervical cancer by FDA priority review qualification	2014-07-24
·	New drugs approved in 2014 will reach 54 for most of the past 10 years	2014-07-24
·	Drug development: Opportunities brought about by changes	2014-07-10
·	Global cancer drug market approaching $100 billion	2014-07-10
·	The Six trends of the future drug development	2014-07-02
·	FDA approved a new inhaled insulin Afrezza coming into the market	2014-07-02
·	FDA again questioned the antibacterial soap and intended to ban it	2014-07-02
·	Pharmaceutical companies are fighting for the first imitation of Six generics	2014-06-27
·	The Internationalization of Traditional Chinese Medicine is Beset with Difficulties	2014-06-27
·	Takeda Introduced the Hypertension Drug Zacras and Azilva in Japan	2014-06-21
·	Takeda Ended The Clinical Project of Prostate Cancer of Orteronel	2014-06-21

Total 130 item(s)　Total 7 Page(s)　Now page:3　 First page Pre Next Last page Jump to page